Iradimed Corporation (NASDAQ:IRMD – Get Free Report) declared a quarterly dividend on Wednesday, October 30th,Zacks Dividends reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.15 per share by the medical equipment provider on Monday, November 25th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date is Friday, November 15th.
Iradimed has a dividend payout ratio of 34.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Iradimed to earn $1.59 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 37.7%.
Iradimed Stock Performance
Shares of Iradimed stock opened at $55.45 on Thursday. Iradimed has a one year low of $40.05 and a one year high of $57.95. The company has a market cap of $702.72 million, a PE ratio of 37.98 and a beta of 0.79. The business has a 50-day simple moving average of $50.30 and a 200-day simple moving average of $46.32.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Iradimed
About Iradimed
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.
Further Reading
- Five stocks we like better than Iradimed
- Investing in the High PE Growth Stocks
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- How to Plot Fibonacci Price Inflection Levels
- Tariff Troubles: 3 Stocks Planning Higher Prices
- What is a support level?
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.